CSTL (STOCKS)
Castle Biosciences, Inc. Common Stock
$32.340000
-0.030000 (-0.09%)
Prev close: $32.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Derek J. Maetzold
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $943.09M
- Employees
- 823
- P/E (TTM)
- -71.92
- P/B (TTM)
- 2.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.02 | $-0.53 | +0.5129 | +96.25% |
|
Jun 2025 (Q2)
|
$0.15 | $-0.53 | +0.6838 | +128.10% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.07 | -0.1275 | -175.86% |
|
Dec 2024 (Q4)
|
$0.33 | $0.05 | +0.2799 | +558.68% |
Financial Statements
| Assets | $562.79M |
| Current Assets | $357.57M |
| Inventory | $8.65M |
| Other Current Assets | $348.92M |
| Noncurrent Assets | $205.22M |
| Liabilities | $95.74M |
| Current Liabilities | $55.31M |
| Accounts Payable | $12.21M |
| Wages | $31.76M |
| Other Current Liabilities | $11.33M |
| Noncurrent Liabilities | $40.43M |
| Long-term Debt | $10.05M |
| Other Non-current Liabilities | $30.38M |
| Equity | $467.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $467.05M |
| Liabilities And Equity | $562.79M |